Market Overview:
The global tapentadol market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic pain, increasing demand for pain relief drugs, and growing awareness about the benefits of tapentadol. The global tapentadol market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into 100 mg tablets, 75 mg tablets 50 mg tablets. On the basis of application, it is segmented into hospital clinics pharmacy other segments.
Product Definition:
Tapentadol is a centrally acting analgesic agent with a dual mode of action as an opioid and non-opioid. It is used for the relief of moderate to severe pain.
100 mg Tablets:
100 mg Tablets is used for the treatment of chronic pain due to osteoarthritis and rheumatoid arthritis. It also provides relief from lower back pain, which is caused by degenerative disc disease. The drug works by decreasing the production of cytokines, which are mainly produced in response to injury or trauma and then sent to the brain for processing as pain signals. As a result, it reduces inflammation along with relieving pain.
75 mg Tablets:
75 mg Tablets is used in the treatment of pain caused by rheumatoid arthritis and osteoarthritis. It is also used to treat chronic back pain, neck pain, and toothache.
The drug works by decreasing the cartilage erosion rate on joint surfaces which reduces inflammation & articular cartilage loss. The medicine does not have any major side effects but may cause drowsiness and blurred vision if taken regularly.
Application Insights:
The hospital application segment accounted for the largest share of 72.4% in 2017 in terms of revenue as well. Tapentadol is a mixture of pentazocine, dihydrocodeine and tramadol, which are opioid analgesic drugs. It is used for the treatment of pain caused by cancer, arthritis and other disorders. The clinic application segment is expected to witness the fastest growth rate over the forecast period owing to increasing awareness about alternative treatments along with rising health care costs across various countries such as U.S., China India etc.
Regional Analysis:
North America dominated the global tapentadol market in 2017. The presence of key players, favorable reimbursement policies, and high healthcare expenditure are some of the factors responsible for its largest share. In addition, increasing awareness about opioid dependence disorders is expected to drive demand over the forecast period.
Asia Pacific is anticipated to witness a lucrative CAGR during the forecast period owing to growing product consumption coupled with rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in public & private health insurance coverage will further boost growth over coming years.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for tapentadol in the coming years.
- Rising prevalence of chronic pain: The prevalence of chronic pain is on the rise due to various factors such as lifestyle changes, obesity, and stress. This is likely to boost the demand for tapentadol in the near future.
- Growing awareness about benefits of tapentadol: There is growing awareness about the benefits of tapentadol among healthcare professionals and patients alike. This is likely to propel its market growth in the coming years.
- Availability of generic versions: The availability of generic versions of tapentadol has made it more affordable for patients, thereby boosting its adoption worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tapentadol Market Research Report
By Type
100 mg Tablets, 75 mg Tablets, 50 mg Tablets
By Application
Hospital, Clinic, Pharmacy, Other
By Companies
Johnson & Johnson Pharmaceutical Research & Development, IPCA Laboratories, Lupin Laboratories, Ranbaxy Laboratories, Aristo Pharmaceuticals, Cadila Pharmaceuticals, Tirupati Medicare, Johnson & Johnson Pharmaceutical Research & Development
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Tapentadol Market Report Segments:
The global Tapentadol market is segmented on the basis of:
Types
100 mg Tablets, 75 mg Tablets, 50 mg Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson Pharmaceutical Research & Development
- IPCA Laboratories
- Lupin Laboratories
- Ranbaxy Laboratories
- Aristo Pharmaceuticals
- Cadila Pharmaceuticals
- Tirupati Medicare
- Johnson & Johnson Pharmaceutical Research & Development
Highlights of The Tapentadol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 100 mg Tablets
- 75 mg Tablets
- 50 mg Tablets
- By Application:
- Hospital
- Clinic
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tapentadol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tapentadol is a medication used to treat pain. It is an opioid drug that works by blocking the receptors in the brain that are responsible for sending signals of pain.
Some of the major companies in the tapentadol market are Johnson & Johnson Pharmaceutical Research & Development, IPCA Laboratories, Lupin Laboratories, Ranbaxy Laboratories, Aristo Pharmaceuticals, Cadila Pharmaceuticals, Tirupati Medicare, Johnson & Johnson Pharmaceutical Research & Development.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tapentadol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tapentadol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tapentadol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tapentadol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tapentadol Market Size & Forecast, 2020-2028
4.5.1 Tapentadol Market Size and Y-o-Y Growth
4.5.2 Tapentadol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 100 mg Tablets
5.2.2 75 mg Tablets
5.2.3 50 mg Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Pharmacy
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tapentadol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tapentadol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 100 mg Tablets
9.6.2 75 mg Tablets
9.6.3 50 mg Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Pharmacy
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 100 mg Tablets
10.6.2 75 mg Tablets
10.6.3 50 mg Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Pharmacy
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 100 mg Tablets
11.6.2 75 mg Tablets
11.6.3 50 mg Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Pharmacy
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 100 mg Tablets
12.6.2 75 mg Tablets
12.6.3 50 mg Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Pharmacy
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 100 mg Tablets
13.6.2 75 mg Tablets
13.6.3 50 mg Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Pharmacy
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tapentadol Market: Competitive Dashboard
14.2 Global Tapentadol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson Pharmaceutical Research & Development
14.3.2 IPCA Laboratories
14.3.3 Lupin Laboratories
14.3.4 Ranbaxy Laboratories
14.3.5 Aristo Pharmaceuticals
14.3.6 Cadila Pharmaceuticals
14.3.7 Tirupati Medicare
14.3.8 Johnson & Johnson Pharmaceutical Research & Development
